Genomics Market Outlook To 2024: Key Product Categories (Instruments, Consumables, Services), Technology (Sequencing, Microarray Technology, PCR, Nucleic Acid Extraction & Purification), Application, Regional Segmentation, Competitive Dynamics, M&A Insights, Pricing Analysis (OPP, IPP, RAP), Ands Segment Forecast

$4,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The global genomics market was valued at $13.5bn in 2016 and is anticipated to reach $28.4bn by 2024.

 

The global genomics market is witnessing lucrative growth owing to factor such as rise in prevalence of chronic diseases, changing lifestyle factors, growing geriatric population, technological advancements such as next-generation sequencing (NGS), and an increase in funding for research & development. The Human Genome Project (HGP), which was an international collaborative research program with a core objective to completely sequence the human gene has triggered the discovery of several new data points about the human genetics.

 

The project was initiated in 1990 with funding received from the U.S. government and several other international agencies. The HGP was declared successful in 2003, and the data generated through this project is the foundation of several modern discoveries about human DNA. The project to completely sequence a single human DNA was completed with an estimated cost of USD 2.7 billion. However, it is now possible to sequence the DNA at USD 5000 due to modern technology and continuous innovations in the field of genomic sequencing.

 

The growing prevalence of chronic diseases such as cancer, neurological, cardiovascular, and other autoimmune diseases, coupled with the rise in geriatric population is a global concern for governments, healthcare providers and other stakeholders. There are more than 80 to 100 autoimmune diseases, however research data is available for only 20-30 conditions. The U.S., National Institute of Health (NIH) based on 24 autoimmune conditions estimates that nearly 23.5 million Americans are suffering from autoimmune diseases. Due to the growing investment in research, the genomics market is expected to grow rapidly over the forecast period.

 

Genomics Market 2024

 

Moreover, genomic research to identify the genotypes leading to the various type of cancers across different regions is a prominent growth driver. As per the World Cancer Research Fund International, Denmark has the highest cancer age-standardized rate for male and female together with 338 people per 100,000 people diagnosed. Moreover, the age-standardized rate was 300 per 100,000 for nine countries including Denmark, Netherlands, U.S., Ireland, Belgium, France, Norway and Republic of Korea.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Genomics Sequencing Products/Services”

 

Estimated Average medical imaging product cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The prices for whole genomic sequence vary based on the type of extraction process, instrument used, sample size, and several other parameters. However, the exosome sequencing prices are much lower than the whole genomic sequencing. For instance, the Illumina exosome sequencing pricing per sample which Includes oligonucleotides, IDT xGen library preparation, and 2X100 sequencing service, prices quoted by Yale Center for Genomic Analysis (YCGA) are as follows,

 

Genomics Pricing

 

Genomics Market by “Product & Technology”

 

The genomics market by product is segmented as instruments/systems, consumables and service. In 2016, consumables accounted for the largest share of over 58% and this segment is expected to extend its dominance over the forecast period. The growing number of tests performed and declining prices of testing are expected to boost the usage of consumables significantly in future.

 

Based on technology, the genomics market is categorized as DNA sequencing, PCR, DNA microarray, and nucleic acid extraction and purification.  The PCR technology accounted for the maximum share of over 48% in 2016, owing to technological advancements, increasing research activity in genomics and proteomics. However, the nucleic acid extraction and purification segment are expected to grow with a lucrative CAGR of over 10% from 2017 to 2024.

 

Genomics Market by “Application”

 

Based on application, the market is segmented as diagnostics, drug discovery, personalized medicine, academic research, agricultural research and others. In 2016, diagnostics segment accounted for over 37% due to rapid growth in the number of molecular diagnostic tests. These tests are used to identify the genes responsible for specific diseases to identify genetic variation across different regions. Over the next few years, the market growth is expected due to the growing demand for personalized medicine. In 2015, The U.S. government announced a personalized medicine initiative (PMI) with an initial funding of USD 130 million to NIH, and USD 70 million for National Cancer Institute to improve the efforts in cancer genomics research. These developments are anticipated to drive the market over the forecast period strongly.

 

Regional Segmentation

 

In 2016, Europe was the leading region with a market share of nearly 42%. The high disease burden, and efforts to drive personalized medicine through the Public Health Genomics European Network (PHGEN) project are some of the crucial factors contributing to the large share of the region. Europe is followed by North America and Asia Pacific.

 

By 2024, North America is expected to be the fastest growing market due to high emphasis on diagnosis through molecular diagnostics and precision medicine. In U.S., the high investment in genomic research, the presence of advanced NGS technologies, and collaboration amongst various stakeholders such as government, academic centers and healthcare practitioners are anticipated to drive the future market expansion. Moreover, some of the biggest companies such as Illumina, Bio-Rad and Roche Diagnostics are rolling out several new products in this market to increase affordability and penetration of the genomics market.

 

Merger & Acquisition Insight

 

The M&A activities in the genomics market are continuously on the rise. The companies dealing with the development of PCR, DNA microarrays and nucleic acid extraction and purification are anticipated to grow rapidly over the next few years and therefore, therefore these players are suitable assets to for merger and acquisition. Some of the most notable transactions in the recent past include,

 

  • In 2017, Thermo Fisher Scientific had acquired Core Informatics, which deals with cloud-based scientific platforms.
  • In 2016, DNA Diagnostics Center had announced the acquisition of IDENTIGENE LLC, which deals with paternity testing and DNA testing services
  • In 2016, Rubicon Genomics had announced a merger deal with Takara Bio USA for an all-stock deal valuation at USD 75 million. The merger is expected to complete by first quarter of 2017

 

Top Players & Company Share

 

Key players operating in the market include Illumina Inc., Pacific Biosciences, Agilent Technologies, GE Healthcare, Life Technologies, Thermo Fischer Scientific, Affymetrix, Inc., Qiagen, BGI, Roche Diagnostics, Bio-Rad Laboratories Inc., and Cepheid. The market is highly competitive in nature and each player has developed a niche target area to increase their profitability and improve investor returns. For instance, Illumina Inc., is a market leader in next-generation sequencing platforms, whereas Roche Diagnostics dominates the molecular diagnostic platforms.

 

Market Segmentation

 

Genomics Market by Product (Revenue, Million, 2014 – 2024)

  • Instruments/Systems
  • Consumables
  • Services

 

Genomics Market by Technology, (Revenue, USD Million, 2014 – 2024)

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery and Development
  • Academic Research
  • Agriculture

Genomics Market by Application (Revenue, USD Million, 2014 – 2024)

  • PCR
  • DNA Sequencing
  • DNA Microarray
  • Nucleic Acid Extraction and Purification

Genomics Market Regional Outlook (Revenue, USD Million, 20124- 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Genomics Market Overview

  • Global Disease Landscape
  • Global Healthcare Expenditure

Chapter 4 Genomics Market Industry Outlook

  • Market Overview
  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Rising Prevalence of Chronic Diseases
    • Increasing Geriatric Population
    • Increasing government support for research and development
    • Growing awareness about genomics
  • Key Market Challenges
    • High cost of Genomics equipment
  • Shortage of trained professionals
  • Privacy and patient data safety issues
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Genomics Market-PESTEL Analysis

Chapter 5: - Genomics Market by “Product” (USD Million)

Genomics Market Landscape by Product Type- 2016 & 2024
  • Instruments/Systems
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Consumables
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Services
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 6: - Genomics Market by “Technology” (USD Million)

Genomics Market Landscape by Technology Type- 2016 & 2024
  • Sequencing
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Microarray Technology
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • PCR (Polymerase Chain Reaction)
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Nucleic Acid Extraction and Purification
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Other Technologies
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 7: - Genomics Market by “Application” (USD Million)

Genomics Market Landscape by End-Use- 2016 & 2024
  • Diagnostics
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Drug Discovery and Development
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Personalized Medicine
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Agriculture & Animal Research
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Other Applications
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 8: Regional Market Outlook

Genomics Market Landscape by Region- 2016
  • North America Market Landscape Analysis, 2016-2024 (USD Mn)
    • U.S. Market Landscape Analysis, 2016-2024
    • Canada Market Landscape Analysis-2016-2024
  • Europe Market Landscape Analysis, 2016-2024 (USD Mn)
    • UK Market Landscape Analysis, 2016-2024
    • Germany Market Landscape Analysis, 2016-2024
    • France Market Landscape Analysis, 2016-2024
    • Italy Market Landscape Analysis, 2016-2024
    • Spain Market Landscape Analysis, 2016-2024
  • Latin America Market Landscape Analysis, 2016-2024 (USD Mn)
    • Brazil Market Landscape Analysis, 2016-2024
    • Mexico Market Landscape Analysis, 2016-2024
    • Colombia Market Landscape Analysis, 2016-2024
  • Asia pacific Market Landscape Analysis, 2016-2024 (USD Mn)
    • Japan Market Landscape Analysis, 2016-2024
    • China Market Landscape Analysis, 2016-2024
    • India Market Landscape Analysis, 2016-2024
  • Middle East & Africa Market Landscape Analysis, 2014-2024 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2014-2024
    • South Africa Market Landscape Analysis, 2014-2024
 

Chapter 9: Pricing Analysis

  Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2016
  • North America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • U.S. Pricing Analysis-2016
    • Canada Pricing Analysis-2016
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2016)
    • UK Pricing Analysis-2016
    • Germany Pricing Analysis-2016
    • France Pricing Analysis-2016
    • Italy Pricing Analysis-2016
    • Spain Pricing Analysis-2016
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Brazil Pricing Analysis-2016
    • Mexico Pricing Analysis-2016
    • Colombia Pricing Analysis-2016
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Japan Pricing Analysis-2016
    • China Pricing Analysis-2016
    • India Pricing Analysis-2016
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Saudi Arabia Pricing Analysis-2016
    • South Africa Pricing Analysis-2016

Chapter 10: Genomics Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline analysis
  • Key R&D trends

Chapter 11: Genomics Merger &Acquisition Outlook

  • Factors driving M&A in smart syringes market
  • Key trends and future outlook

Chapter 12: Genomics Regulatory & Patent Outlook

  • Regulatory Landscape by Region (U.S., Europe, and RoW)
  • Patent Landscape by Region (U.S., Europe, and RoW)

Chapter 13: Competitive Landscape

  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • GE Healthcare
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Illumina, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Roche Holding AG
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Thermo Fisher Scientific, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Agilent Technologies, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Affymetrix, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Beijing Genomics Institute (BGI)
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Cepheid, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Eurofins Genomics, Inc.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  • Qiagen N.V.
    • Company Overview
    • Financial Performance
    • Key Decision Maker
    • Product Pipeline
    • Strategic Initiative
  List of Tables  
  • TABLE 1 Genomics Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2 Global Genomics Market, 2014 – 2024
  • TABLE 3 Global Genomics Market Analysis by Product-2016
  • TABLE 4 Global Genomics Market Analysis by Technology -2016
  • TABLE 5 Global Genomics Market Analysis by Application-2016
  • TABLE 7 Global Genomics Market Analysis by Geography-2016
  • TABLE 8 Global Genomics Market Analysis by Leading Brands-2016
  • TABLE 9 Genomics Market - Key market driver analysis
  • TABLE 10 Genomics Market - Key market restraint analysis
  • TABLE 11 North America Market Genomics Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 12U.S. Genomics Market Landscape Analysis, 2016-2024
  • TABLE 13 Canada Genomics Market Landscape Analysis, 2016-2024
  • TABLE 14 Europe Genomics Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 15 U.K Genomics Market Landscape Analysis, 2016-2024
  • TABLE 16 Germany Genomics Market Landscape Analysis, 2016-2024
  • TABLE 17 France Genomics Market Landscape Analysis, 2016-2024
  • TABLE 18 Italy Genomics Market Landscape Analysis, 2016-2024
  • TABLE 19 Spain Genomics Market Landscape Analysis, 2016-2024
  • TABLE 20 Latin America Genomics Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 21 Brazil Genomics Market Landscape Analysis, 2016-2024
  • TABLE 22 Mexico Genomics Market Landscape Analysis, 2016-2024
  • TABLE 20 Colombia Genomics Market Landscape Analysis, 2016-2024
  • TABLE 21 Asia pacific Genomics Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 22 Japan Genomics Market Landscape Analysis, 2016-2024
  • TABLE 23 China Genomics Market Landscape Analysis, 2016-2024
  • TABLE 24 India Genomics Market Landscape Analysis, 2016-2024
  • TABLE 25 North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 27 U.S. Pricing Analysis-2016
  • TABLE 28 Canada Pricing Analysis-2016
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 30 U.K Pricing Analysis-2016
  • TABLE 31 Germany Pricing Analysis-2016
  • TABLE 32 France Pricing Analysis-2016
  • TABLE 33 Italy Pricing Analysis-2016
  • TABLE 34 Spain Pricing Analysis-2016
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 36 Brazil Pricing Analysis-2016
  • TABLE 37 Mexico Pricing Analysis-2016
  • TABLE 38 Colombia Pricing Analysis-2016
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 40 Japan Pricing Analysis-2016
  • TABLE 41 China Pricing Analysis-2016
  • TABLE 42 India Pricing Analysis-2016
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 44 Saudi Arabia Pricing Analysis-2016
  • TABLE 45 South Africa Pricing Analysis-2016
  List of Figures  
  • 1 Genomics Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Genomics Market – PESTEL Analysis
  • 7 Genomics Market Share by Product Type, 2016 & 2024
  • 8 Genomics Market Share by Technology Type, 2016 & 2024
  • 9 Genomics Market Share by Application Type, 2016 & 2024
  • 10 Genomics Market Share by Region, 2016 & 2024

Key Insights Addressed:  

  • Defining market size from 2014 to 2016.
  • Estimating market growth till 2024 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:    
  • The global genomics market was valued at $13.5bn in 2016 and is anticipated to reach $28.4bn by 2024.
  • The global genomics market is witnessing lucrative growth owing to factor such as rise in prevalence of chronic diseases, changing lifestyle factors, growing geriatric population, technological advancements such as next-generation sequencing (NGS), and increase in funding for research & development.
  • The project to completely sequence a single human DNA was completed with an estimated cost of USD 2.7 billion. However, it is now possible to sequence the DNA at USD 5000 due to modern technology and continuous innovations in the field of genomic sequencing.
  • Key players operating in the market include Illumina Inc., Pacific Biosciences, Agilent Technologies, GE Healthcare, Life Technologies, Thermo Fischer Scientific, Affymetrix, Inc., Qiagen, BGI, Roche Diagnostics, Bio-Rad Laboratories Inc., and Cepheid.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The global genomics market was valued at $13.5bn in 2016 and is anticipated to reach $28.4bn by 2024.

 

The global genomics market is witnessing lucrative growth owing to factor such as rise in prevalence of chronic diseases, changing lifestyle factors, growing geriatric population, technological advancements such as next-generation sequencing (NGS), and an increase in funding for research & development. The Human Genome Project (HGP), which was an international collaborative research program with a core objective to completely sequence the human gene has triggered the discovery of several new data points about the human genetics.

 

The project was initiated in 1990 with funding received from the U.S. government and several other international agencies. The HGP was declared successful in 2003, and the data generated through this project is the foundation of several modern discoveries about human DNA. The project to completely sequence a single human DNA was completed with an estimated cost of USD 2.7 billion. However, it is now possible to sequence the DNA at USD 5000 due to modern technology and continuous innovations in the field of genomic sequencing.

 

The growing prevalence of chronic diseases such as cancer, neurological, cardiovascular, and other autoimmune diseases, coupled with the rise in geriatric population is a global concern for governments, healthcare providers and other stakeholders. There are more than 80 to 100 autoimmune diseases, however research data is available for only 20-30 conditions. The U.S., National Institute of Health (NIH) based on 24 autoimmune conditions estimates that nearly 23.5 million Americans are suffering from autoimmune diseases. Due to the growing investment in research, the genomics market is expected to grow rapidly over the forecast period.

 

Genomics Market 2024

 

Moreover, genomic research to identify the genotypes leading to the various type of cancers across different regions is a prominent growth driver. As per the World Cancer Research Fund International, Denmark has the highest cancer age-standardized rate for male and female together with 338 people per 100,000 people diagnosed. Moreover, the age-standardized rate was 300 per 100,000 for nine countries including Denmark, Netherlands, U.S., Ireland, Belgium, France, Norway and Republic of Korea.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Genomics Sequencing Products/Services”

 

Estimated Average medical imaging product cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The prices for whole genomic sequence vary based on the type of extraction process, instrument used, sample size, and several other parameters. However, the exosome sequencing prices are much lower than the whole genomic sequencing. For instance, the Illumina exosome sequencing pricing per sample which Includes oligonucleotides, IDT xGen library preparation, and 2X100 sequencing service, prices quoted by Yale Center for Genomic Analysis (YCGA) are as follows,

 

Genomics Pricing

 

Genomics Market by “Product & Technology”

 

The genomics market by product is segmented as instruments/systems, consumables and service. In 2016, consumables accounted for the largest share of over 58% and this segment is expected to extend its dominance over the forecast period. The growing number of tests performed and declining prices of testing are expected to boost the usage of consumables significantly in future.

 

Based on technology, the genomics market is categorized as DNA sequencing, PCR, DNA microarray, and nucleic acid extraction and purification.  The PCR technology accounted for the maximum share of over 48% in 2016, owing to technological advancements, increasing research activity in genomics and proteomics. However, the nucleic acid extraction and purification segment are expected to grow with a lucrative CAGR of over 10% from 2017 to 2024.

 

Genomics Market by “Application”

 

Based on application, the market is segmented as diagnostics, drug discovery, personalized medicine, academic research, agricultural research and others. In 2016, diagnostics segment accounted for over 37% due to rapid growth in the number of molecular diagnostic tests. These tests are used to identify the genes responsible for specific diseases to identify genetic variation across different regions. Over the next few years, the market growth is expected due to the growing demand for personalized medicine. In 2015, The U.S. government announced a personalized medicine initiative (PMI) with an initial funding of USD 130 million to NIH, and USD 70 million for National Cancer Institute to improve the efforts in cancer genomics research. These developments are anticipated to drive the market over the forecast period strongly.

 

Regional Segmentation

 

In 2016, Europe was the leading region with a market share of nearly 42%. The high disease burden, and efforts to drive personalized medicine through the Public Health Genomics European Network (PHGEN) project are some of the crucial factors contributing to the large share of the region. Europe is followed by North America and Asia Pacific.

 

By 2024, North America is expected to be the fastest growing market due to high emphasis on diagnosis through molecular diagnostics and precision medicine. In U.S., the high investment in genomic research, the presence of advanced NGS technologies, and collaboration amongst various stakeholders such as government, academic centers and healthcare practitioners are anticipated to drive the future market expansion. Moreover, some of the biggest companies such as Illumina, Bio-Rad and Roche Diagnostics are rolling out several new products in this market to increase affordability and penetration of the genomics market.

 

Merger & Acquisition Insight

 

The M&A activities in the genomics market are continuously on the rise. The companies dealing with the development of PCR, DNA microarrays and nucleic acid extraction and purification are anticipated to grow rapidly over the next few years and therefore, therefore these players are suitable assets to for merger and acquisition. Some of the most notable transactions in the recent past include,

 

  • In 2017, Thermo Fisher Scientific had acquired Core Informatics, which deals with cloud-based scientific platforms.
  • In 2016, DNA Diagnostics Center had announced the acquisition of IDENTIGENE LLC, which deals with paternity testing and DNA testing services
  • In 2016, Rubicon Genomics had announced a merger deal with Takara Bio USA for an all-stock deal valuation at USD 75 million. The merger is expected to complete by first quarter of 2017

 

Top Players & Company Share

 

Key players operating in the market include Illumina Inc., Pacific Biosciences, Agilent Technologies, GE Healthcare, Life Technologies, Thermo Fischer Scientific, Affymetrix, Inc., Qiagen, BGI, Roche Diagnostics, Bio-Rad Laboratories Inc., and Cepheid. The market is highly competitive in nature and each player has developed a niche target area to increase their profitability and improve investor returns. For instance, Illumina Inc., is a market leader in next-generation sequencing platforms, whereas Roche Diagnostics dominates the molecular diagnostic platforms.

 

Market Segmentation

 

Genomics Market by Product (Revenue, Million, 2014 – 2024)

  • Instruments/Systems
  • Consumables
  • Services

 

Genomics Market by Technology, (Revenue, USD Million, 2014 – 2024)

  • Diagnostics
  • Personalized Medicine
  • Drug Discovery and Development
  • Academic Research
  • Agriculture

Genomics Market by Application (Revenue, USD Million, 2014 – 2024)

  • PCR
  • DNA Sequencing
  • DNA Microarray
  • Nucleic Acid Extraction and Purification

Genomics Market Regional Outlook (Revenue, USD Million, 20124- 2024)

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
    • Columbia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650